Novartis AG is 172.8x more valuable than MBX Biosciences, Inc. by market capitalization ($292.08 B vs $1.69 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MBX | NVS |
|---|---|---|
| Market cap | $1.69 B | $292.08 B |
| US-listed rank | #2238 | #47 |
| Net income (latest FY) | -$87.00M | - |
| SEC filings | 198 | 947 |
Novartis AG is 172.8x more valuable than MBX Biosciences, Inc. by market capitalization ($292.08 B vs $1.69 B).
Full pages: MBX Biosciences, Inc. and Novartis AG, or browse the full rankings.